Interview with P.F. Bongers, Chairman, Bogin
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
Address: Lange Kleiweg 52 J –
2288 GK Rijswijk – the Netherlands
Tel: +31 0 70 413 20 80
Young and fast growing, Chiesi Netherlands is an affiliate that was started from the ground up. In 2009, Chiesi Netherlands launched Atimos, re-launched Curosurf (sales rights re-acquired by Chiesi), and licensed-in Aggrastat.
The new management team reorganised the affiliate to manage its expansion in the best way possible, and to be prepared for the rapidly changing pharmaceutical market in the Netherlands.
Partnerships were established with the local medical and scientific communities in the main therapeutic areas Chiesi serves (respiratory, cystic fibrosis, and neonatology).
The 2010 targets include expanding the products in all therapeutic areas and improving the company’s image among all relevant stakeholders in the Netherlands
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general manager of this Dutch affiliate.…
Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What…
When it comes to the pharmaceutical and healthcare industries in the Netherlands, the country has one of the highest generic penetration rates in Europe, it does not have a strong…
WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week showed another strong focus on the…
Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities and, in 2010, you doubled the size of…
Founded in 1997 Actelion is certainly the “new kid on the block” when compared to some of the much older mainstays in the pharmaceutical industry. What would you say was…
A very strong phrase that we recently came across describes a “war going on in the generics industry” as a result of the preference policy, which people have claimed has…
Bioceros was founded as a service company built on the immunology expertise of its founders. Additional cell line expertise was added when you joined in 2007. What made this combination…
As the founder of the Institute of Young Entrepreneurs at the Delft University of Technology and an enthusiastic promoter of innovation and new technologies, what do you believe distinguishes a…
We do not often meet companies that have been successful at retaining their manufacturing facilities in the Netherlands. How and why did former Katwijk Farma -and now Apotex- succeed to…
Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising.…
See our Cookie Privacy Policy Here
